As of 31 Dec 2025, 5 institutional investors reported holding $26,450,000 in principal (par value) of NOVAVAX INC - NOTE 5.000%12/1.
| Period | Principal | Value | Change | Price (% of par) (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | $26,450,000 | $28,386,937 | -$60 | 107.12% | 5 |
| 2025 Q3 | $26,450,000 | $30,404,234 | -$155,021,702 | 115.5% | 4 |
| 2025 Q2 | $163,048,538 | $182,358,532 | +$13,684,753 | 99.51% | 11 |
| 2025 Q1 | $155,246,538 | $161,285,806 | -$72,997 | 91.55% | 10 |
| 2024 Q4 | $155,246,538 | $174,990,874 | +$4,051,234 | 99.85% | 12 |
| 2024 Q3 | $150,447,288 | $215,375,138 | +$1,013,631 | 126.36% | 11 |
| 2024 Q2 | $153,943,188 | $211,694,326 | +$31,245,216 | 124.59% | 12 |
| 2024 Q1 | $142,830,000 | $91,450,799 | +$89,543,664 | 62.25% | 15 |